The estimated risk of developing Guillain-Barré Syndrome (GBS) is relatively low. The risk is one to two cases per 100,000 people per year. According to research, infections from external infectious agents that cause severe autoimmune responses are considered major factors in starting the syndrome.
Here's a breakdown of the risk:
- Overall Risk: 1-2 cases per 100,000 people annually.
- Major Initiating Factors: Autoimmune responses often triggered by infections.
In summary, the risk of developing GBS is rare.